PFN2 and nasopharyngeal carcinoma: This integrated perspective proposes a multi‐axial mechanism wherein ceRNA‐mediated regulation of PLA2R1 and PFN2 converges with metabolic reprogramming and immune modulation to drive NPC relapse, providing a compelling framework for future mechanistic investigation.